/
DCF Valuation
Base-case fair value
$74.39
Intrinsic $99.19 · 25% MOS
Current price: $51.29
Base-case summary
Our base-case DCF for Veracyte, Inc. (VCYT) projects 10 years of free cash flow growth at 20.0% for years 1–5 and 10.0% for years 6–10, anchored to 65.5% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $155M in trailing free cash flow, this produces an intrinsic value of $99.19 per share. A 25% safety margin gives a fair value of $74.39, suggesting the stock is currently 45% undervalued against the $51.29 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$155M
Cash & equivalents
$263M
Total debt
$39M
Shares outstanding
81M